This entry was posted
on Sunday, July 1st, 2012 at 1:34 pm and is filed under Science News.
You can subscribe via RSS 2.0 feed to this post's comments.
You can comment below, or link to this permanent URL from your own site.
Your comments will be moderated but will appear as soon as humanly possible.
One Comment on “Competitors Form Partnership to Develop Autism Drugs”
These drugs that are being developed seem only to address symptoms, not causes. GcMAF is being trialled in the treatment of autism and has been described by one clinic as the most important discovery in the treatment of autism to date. It restores the immune system, and this has the knock on effect of improving the symptoms of autism in over 80% of participants. The use of gcMAF in the treatment of autism has been pioneered by Dr Bradstreet in the USA and is now being used across the world as clinics become aware of the amazing changes that GcMAF can have to the patients and thier families
Now accepting donations for the maintenance and growth of International- Psychoanalysis.net